| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/10/2002 | CN1087345C Human vascular IBP-like growth factor |
| 07/10/2002 | CN1087344C Transforming growth factor alpha-H1 |
| 07/10/2002 | CN1087283C New LH-RH antigonists with improved effectiveness |
| 07/10/2002 | CN1087176C Vaccine compositions containing 3-O deacylated monophosphoryl lipid A |
| 07/09/2002 | US6417429 Genetic engineering |
| 07/09/2002 | US6417397 Drug delivery, bioavailability; prodrugs |
| 07/09/2002 | US6417387 α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 07/09/2002 | US6417338 Accumulation, concentration of polypeptide |
| 07/09/2002 | US6417335 Protein purification |
| 07/09/2002 | US6417334 Antagonists to chaperonin 10 |
| 07/09/2002 | US6417333 Modified human parathyroid hormone |
| 07/09/2002 | US6417331 Polypeptides |
| 07/09/2002 | US6417329 Purified polypeptide |
| 07/09/2002 | US6417327 Peptide capable of regulating physiological function of FGF-5 and pharmaceutical composition containing the peptide |
| 07/09/2002 | US6417325 Administering cyclic peptide |
| 07/09/2002 | US6417237 Macromolecular drug complexes and compositions containing the same |
| 07/09/2002 | US6417227 Methods of delivery of cetyl myristoleate |
| 07/09/2002 | US6417221 Tropane analogs and methods for inhibition of monoamine transport |
| 07/09/2002 | US6417205 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/09/2002 | US6417173 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/09/2002 | US6417169 Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to inhibit cell growth |
| 07/09/2002 | US6417168 Anticancer treatment with killing cells |
| 07/09/2002 | US6417166 Thin mineralized collagen membrane and method of making same |
| 07/09/2002 | US6417165 NY-ESO-1-peptide derivatives, and uses thereof |
| 07/09/2002 | US6417164 Treatment of noninsulin diabetes with amylin agonist |
| 07/09/2002 | US6417163 Compositions and methods for controlling plant pests |
| 07/09/2002 | US6417162 Female impotence treated with heterocyclic compound containing nitro groups |
| 07/09/2002 | US6417161 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors |
| 07/09/2002 | US6417159 Method of enhancing effect of a neurotrophin with analogues of p75NTR367-379. |
| 07/09/2002 | US6417158 Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF |
| 07/09/2002 | US6417010 Methods and apparatus for synthesizing labeled combinatorial chemistry libraries |
| 07/09/2002 | US6416998 Polypeptides |
| 07/09/2002 | US6416996 Hepatitis b virus genome |
| 07/09/2002 | US6416991 Genetic engineered protein |
| 07/09/2002 | US6416990 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/09/2002 | US6416987 Mutants of thymidylate synthase and uses thereof |
| 07/09/2002 | US6416984 Human DNA mismatch repair proteins |
| 07/09/2002 | US6416976 TrpS |
| 07/09/2002 | US6416974 Tango 71 nucleic acids |
| 07/09/2002 | US6416973 Nucleic acids encoding mammalian cell membrane protein MDL-1 |
| 07/09/2002 | US6416972 Purified hybrid nucleic acid |
| 07/09/2002 | US6416971 Soluble, single chain t cell receptor encoded by specified nucleic acid sequence |
| 07/09/2002 | US6416963 Cleaved fragments of fibrinogen |
| 07/09/2002 | US6416958 Antibody binds an epitope on the hla-dr polypeptide and induces apoptosis in cells expressing hla-dr, without concomitant suppression of hla-dr dependent immune responses. |
| 07/09/2002 | US6416956 Screening for and/or diagnosing breast cancer by obtaining cell sample from patient and determining whether bp1 is overexpressed by said cell sample as compared to normal cells |
| 07/09/2002 | US6416954 Modulating binding of t-helper cells to ccr8 ligand comprising contacting cells with viral macrophage inflammatory protein i |
| 07/09/2002 | US6416794 Methods and compositions for treating cataracts using substances derived from yeast or saltbush |
| 07/09/2002 | US6416783 Aspartic and malic acid inhibition of ss-glucuronidase |
| 07/09/2002 | US6416765 Botulinum toxin injected into the pancreas |
| 07/09/2002 | US6416760 Therapeutic/cosmetic formulation for therapeutical treatment or care of sensitive human skin, hair, mucous membrane, nails and/or the scalp comprises a calcitonin gene related peptide (cgrp) antagonist and a carrier, diluent or vehicle |
| 07/09/2002 | US6416757 Tumor necrosis factor antibodies |
| 07/09/2002 | US6416753 Method for modulating apoptosis |
| 07/09/2002 | US6416739 Microparticles and their therapeutic or diagnostic use |
| 07/09/2002 | US6416734 Recombinant alpha-fetoprotein for treating and diagnosing cancers |
| 07/09/2002 | US6415797 Treatment of human herpesviruses using hyperthermia |
| 07/09/2002 | CA2366766A1 Glycoprotein matrix compositions and methods related thereto |
| 07/09/2002 | CA2328831A1 Antibiotics as quorum-sensing autoinducers |
| 07/09/2002 | CA2292012C Inhibitor of helicobacter pylori colonization |
| 07/09/2002 | CA2264189C Homocysteine desulphurase from the protozoan trichomonas vaginalis |
| 07/09/2002 | CA2233170C Lactose-containing food composition for infants |
| 07/09/2002 | CA2221793C Novel antibacterial protein |
| 07/09/2002 | CA2099866C Antibiotic a 40926 ester derivatives |
| 07/09/2002 | CA2053468C Prolonged release preparation and polymers thereof |
| 07/09/2002 | CA1341375C Compositions and methods for the treatment and prevention of gram-negative bacterial infections |
| 07/09/2002 | CA1341374C Compositions and method for treatment of cancer using monoclonal antibody against gd3 ganglioside together with il-2 |
| 07/08/2002 | CA2366780A1 Stabilized liquid preparation of the protease which activates blood coagulation factor vii, or of its proenzyme |
| 07/04/2002 | WO2002052274A2 Screening method based on tsap6 binding partners |
| 07/04/2002 | WO2002052273A1 Screening method based on siah-numb interaction |
| 07/04/2002 | WO2002052270A2 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 07/04/2002 | WO2002052269A2 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 07/04/2002 | WO2002052268A1 A screening assay for antagonists of human leukocyte receptors |
| 07/04/2002 | WO2002052030A2 Compositions and methods enabling a totally internally controlled amplification reaction |
| 07/04/2002 | WO2002052022A2 Selective cytotoxic fusion proteins |
| 07/04/2002 | WO2002052019A2 22437, a human sulfatase and uses therefor |
| 07/04/2002 | WO2002052016A2 Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme |
| 07/04/2002 | WO2002052011A2 A novel human leucine-rich repeat containing protein expressed predominately in bone marrow, hlrrbm1 |
| 07/04/2002 | WO2002052009A1 Human fgf23 protein mutant lowering blood phosphorus level |
| 07/04/2002 | WO2002052007A1 Synovial membrane cell protein |
| 07/04/2002 | WO2002052004A1 Gene involved in apoptosis regulation |
| 07/04/2002 | WO2002052001A1 Method of identifying dna encoding physiologically active polypeptide in mammalian body |
| 07/04/2002 | WO2002051999A1 Novel atopic dermatitis-associated gene and proteins |
| 07/04/2002 | WO2002051996A2 Regulation of human cyclophilin-like protein |
| 07/04/2002 | WO2002051994A2 Polypeptides |
| 07/04/2002 | WO2002051993A1 MAP kinase integrin-binding domain |
| 07/04/2002 | WO2002051989A2 Human 4-nitrophenylphosphatase |
| 07/04/2002 | WO2002051986A2 Educated nk t cells and their uses in the treatment of immune-related disorders |
| 07/04/2002 | WO2002051981A2 Defects in periaxin associated with myelinopathies |
| 07/04/2002 | WO2002051979A2 Method to remove citrate and aluminum from proteins |
| 07/04/2002 | WO2002051871A2 Anti-cd28 antibody |
| 07/04/2002 | WO2002051869A1 Compounds comprising two or more identical protein domains interlinked by a peptide having such a length that each of the protein domains can interact simultaneously with its specific cell-surface structure and thereby block the function of the structure |
| 07/04/2002 | WO2002051868A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2002051867A1 A novel polypeptide-corticotropin releasing factor 8.8 and the polynucleotide encoding said polypeptide |
| 07/04/2002 | WO2002051866A2 Antibacterial treatments |
| 07/04/2002 | WO2002051863A2 Polypeptides having a triggering nk activity and biological applications |
| 07/04/2002 | WO2002051862A2 Cytostatic-glycoconjugates having specifically cleavable peptidiclinking units |
| 07/04/2002 | WO2002051860A2 Synthetic peptide composition as immunogens for prevention of urinary tract infection |
| 07/04/2002 | WO2002051858A2 Antisense modulation of chk2 expression |
| 07/04/2002 | WO2002051846A1 Apicidin-derivatives, their synthetic methods, and antitumor compositions containing the same |
| 07/04/2002 | WO2002051492A1 Vessel enlargement by arteriogenic factor delivery |
| 07/04/2002 | WO2002051460A2 Bioactive materials for aneurysm repair |